Nakamura Hirotoshi
Second Division, Department of Medicine, Hamamatsu University School of Medicine.
Nihon Rinsho. 2007 Nov;65(11):1937-42.
The incidence of thyroid cancer clinically detected is increasing, mainly due to the technical progress in thyroid sonography. There are many problems and questions regarding the management of patients with thyroid tumors, including how to distinct thyroid follicular cancer from adenoma (no definite method is available except for the histological examination of the tissue specimen at surgery), how to treat patients with unproved thyroid tumor (thyroidectomy or observation ?), how to define "poorly differentiated thyroid cancer" (different definition between WHO and Japan) and how to treat patients with differentiated thyroid cancer (total thyroidectomy or subtotal thyroidectomy, with or without prophylactic neck dissection, with or without postoperative remnant ablation by radioactive iodine, with or without postoperative TSH suppression by thyroid hormone, thyroidectomy or observation for micro-carcinoma). Several guidelines for management of thyroid tumors have recently been published from western thyroid associations. Their basic policy how to manage differentiated thyroid cancer is considerably different from, at least, the traditional treatment in Japan. An evidence-based guideline should be published soon in
临床检测到的甲状腺癌发病率正在上升,主要归因于甲状腺超声检查技术的进步。关于甲状腺肿瘤患者的管理存在许多问题,包括如何将甲状腺滤泡癌与腺瘤区分开来(除了手术时对组织标本进行组织学检查外,没有确定的方法),如何治疗未经证实的甲状腺肿瘤患者(甲状腺切除术还是观察?),如何定义“低分化甲状腺癌”(世界卫生组织和日本之间的定义不同)以及如何治疗分化型甲状腺癌患者(全甲状腺切除术还是次全甲状腺切除术,是否进行预防性颈清扫,是否进行术后放射性碘残留消融,是否进行术后甲状腺激素抑制促甲状腺激素,对微癌进行甲状腺切除术还是观察)。西方甲状腺协会最近发布了几项甲状腺肿瘤管理指南。他们管理分化型甲状腺癌的基本政策至少与日本的传统治疗方法有很大不同。不久应会发布基于证据的指南。